Your Cart is Empty
Statins are currently being used by millions of Americans to reduce cholesterol and to prevent heart disease. A recent study reveals that statins may reduce circulating GLP-1 levels, potentially disrupting metabolism, increasing insulin resistance, and elevating blood sugar. This interference affects GLP-1, the hormone mimicked by weight-loss drugs like Ozempic, highlighting an overlooked metabolic impact.
GLP-1 is crucial for blood sugar control, boosting insulin release and supporting glucose balance. Lower GLP-1 levels can disrupt these processes, causing insulin resistance and elevated blood sugar. Taking a statin alongside a medication like Ozempic may diminish some of its intended effects, especially those related to managing blood sugar.
The study consisted of 30 participants, taking the drug atorvastatin. They were monitored for four months with various controls. While cholesterol levels dropped as anticipated, blood sugar slightly increased, insulin resistance worsened, and GLP-1 levels decreased by nearly 50%.
The study revealed that statins modify the gut microbiome, particularly reducing Clostridium bacteria, which produce UDCA, a bile acid that supports GLP-1 production. With reduced microbes, UDCA levels dropped, leading to lower GLP-1. Essentially, statins disrupted a gut microbial pathway critical for blood sugar regulation.
Many doctors prescribe statins without discussing their impact on insulin resistance or overall metabolic health. For patients managing cholesterol and blood sugar, this overlooked connection is vital.
Lifestyle interventions are indeed critical as a first-line approach to support and maintain metabolic health, especially for individuals on statins. Prioritizing lifestyle changes can enhance the effectiveness of statins, potentially reduce reliance on medication, and improve overall health.
To view the original scientific study click below:
Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner
Sugar sweetened drinks have faced criticism for years, with diet versions often viewed as safer. A new study ties both sugar-filled and artificially sweetened drinks to elevated chances of metabolic dysfunction-associated steatotic liver disease (MASLD), the severe liver disorder previously named nonalcoholic fatty liver disease. This occurs when fat accumulates in the livers of individuals who rarely or never drink alcohol.
Regular exercise keeps your body and brain sharp as you age. It preserves mobility, supports independence, and may slow cognitive decline. New research shows exercise reprograms the body at the molecular level, fundamentally transforming biological systems from the inside out.
Do you sleep in total darkness, or is there a glow in your bedroom? New, groundbreaking research shows that eliminating light during sleep may help guard you from heart disease. Researchers gathered the data by following UK Biobank participants’ heart health records for over 9 years by monitoring them with a wrist light sensor.